These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18949270)

  • 1. Quantification of cerebrospinal fluid ferritin as a biomarker for CNS malignant infiltration.
    Almeida SM; Cunha DS; Yamada E; Doi EM; Ono M
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):720-4. PubMed ID: 18949270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid cytological and biochemical characteristics in the presence of CNS neoplasia.
    Almeida SM; Nanakanishi E; Conto AJ; Souza LP; Antonelli Filho D; Roda CD
    Arq Neuropsiquiatr; 2007 Sep; 65(3B):802-9. PubMed ID: 17952285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid ferritin--unspecific and unsuitable for disease monitoring.
    Kolodziej MA; Proemmel P; Quint K; Strik HM
    Neurol Neurochir Pol; 2014; 48(2):116-21. PubMed ID: 24821637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.
    Gu W; Rauschecker AM; Hsu E; Zorn KC; Sucu Y; Federman S; Gopez A; Arevalo S; Sample HA; Talevich E; Nguyen ED; Gottschall M; Nourbakhsh B; Gold CA; Cree BAC; Douglas VC; Richie MB; Shah MP; Josephson SA; Gelfand JM; Miller S; Wang L; Tihan T; DeRisi JL; Chiu CY; Wilson MR
    JAMA Neurol; 2021 Nov; 78(11):1355-1366. PubMed ID: 34515766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
    Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
    Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.
    Strehlow F; Bauer S; Martus P; Weller M; Roth P; Schlegel U; Seidel S; Scheibenbogen C; Korfel A; Kreher S
    J Neurooncol; 2016 Aug; 129(1):165-71. PubMed ID: 27294357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ferritin in the cerebrospinal fluid as an early indicator of neuromeningeal involvement in patients with malignant lymphoma].
    Aviles A; Gómez R; Salas J
    Gac Med Mex; 1991; 127(3):249-52. PubMed ID: 1800218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid ferritin in malignant CNS involvement.
    Zandman-Goddard G; Matzner Y; Konijn AM; Hershko C
    Cancer; 1986 Sep; 58(6):1346-9. PubMed ID: 3742459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-2-microglobulin and ferritin in cerebrospinal fluid for evaluation of patients with meningitis of different etiologies.
    Takahashi S; Oki J; Miyamoto A; Moriyama T; Asano A; Inyaku F; Okuno A
    Brain Dev; 1999 Apr; 21(3):192-9. PubMed ID: 10372906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid ferritin in patients with leukaemia and malignant lymphoma.
    Milman N; Vig L; Pedersen NS; Olsen TS
    Scand J Haematol; 1985 Aug; 35(2):132-6. PubMed ID: 3863234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of CRP, Procalcitonin, and Ferritin Levels in Cerebrospinal Fluid of Children with Meningitis.
    Shokrollahi MR; Shabanzadeh K; Noorbakhsh S; Tabatabaei A; Movahedi Z; Shamshiri AR
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):58-62. PubMed ID: 26931764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid biomarkers of malignancies located in the central nervous system.
    Verheul C; Kleijn A; Lamfers MLM
    Handb Clin Neurol; 2017; 146():139-169. PubMed ID: 29110768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis.
    Müller HL; Oh Y; Gargosky SE; Lehrnbecher T; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1113-9. PubMed ID: 7521338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.
    Mattox AK; Yan H; Bettegowda C
    Neuro Oncol; 2019 Dec; 21(12):1509-1518. PubMed ID: 31595305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
    Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
    Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cerebrospinal fluid osteopontin level and central nervous system involvement in childhood acute leukemia.
    Incesoy-Özdemir S; Sahin G; Bozkurt C; Oren AC; Balkaya E; Ertem U
    Turk J Pediatr; 2013; 55(1):42-9. PubMed ID: 23692831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.
    Nguyen-Them L; Costopoulos M; Tanguy ML; Houillier C; Choquet S; Benanni H; Elias-Shamieh R; Armand M; Faivre G; Glaisner S; Malak S; Vargaftig J; Hoang-Xuan K; Ahle G; Touitou V; Cassoux N; Davi F; Merle-Béral H; Le Garff-Tavernier M; Soussain C;
    Eur J Cancer; 2016 Jul; 61():69-76. PubMed ID: 27156226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.